Leap Therapeutics, Inc.

Informe acción NasdaqCM:LPTX

Capitalización de mercado: US$123.2m

Salud financiera de hoja de balance de Leap Therapeutics

Salud financiera controles de criterios 6/6

Leap Therapeutics tiene un patrimonio de los accionistas total de $60.1M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $72.8M y $12.7M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$70.64m
PatrimonioUS$60.14m
Total pasivoUS$12.68m
Activos totalesUS$72.83m

Actualizaciones recientes sobre salud financiera

Recent updates

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?

Mar 13
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?

Will Leap Therapeutics (NASDAQ:LPTX) Spend Its Cash Wisely?

Nov 22
Will Leap Therapeutics (NASDAQ:LPTX) Spend Its Cash Wisely?

Leap Therapeutics GAAP EPS of -$0.15 misses by $0.05

Aug 12

Leap Therapeutics begins trials of DKN-01 in gastric/colorectal cancers

Jul 12

Leap Therapeutics: 2 Catalysts With Cancer Drug DKN-01 In The 2nd Half Of 2022

Jun 27

Here's Why We're Watching Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Situation

May 01
Here's Why We're Watching Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Situation

Leap Therapeutics: Waiting For One More Leap

Feb 18

We're Hopeful That Leap Therapeutics (NASDAQ:LPTX) Will Use Its Cash Wisely

Jan 04
We're Hopeful That Leap Therapeutics (NASDAQ:LPTX) Will Use Its Cash Wisely

Leap Therapeutics: What Prompted Prioritizing This Precision Oncology Company?

Nov 29

Leap Therapeutics: All On The Line

Oct 13

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Sep 15
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Jun 01
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Companies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth

Mar 03
Companies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth

Could The Leap Therapeutics, Inc. (NASDAQ:LPTX) Ownership Structure Tell Us Something Useful?

Jan 27
Could The Leap Therapeutics, Inc. (NASDAQ:LPTX) Ownership Structure Tell Us Something Useful?

Announcing: Leap Therapeutics (NASDAQ:LPTX) Stock Increased An Energizing 127% In The Last Year

Dec 23
Announcing: Leap Therapeutics (NASDAQ:LPTX) Stock Increased An Energizing 127% In The Last Year

Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)

Nov 18
Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($71.6M) de LPTX superan a sus pasivos a corto plazo ($12.7M).

Pasivo a largo plazo: LPTX no tiene pasivos a largo plazo.


Historial y análisis de deuda-patrimonio

Nivel de deuda: LPTX está libre de deudas.

Reducción de la deuda: LPTX no tenía deudas hace 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: LPTX tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.

Pronóstico de cash runway: LPTX dispone de suficiente cash runway para 1.2 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 15% cada año.


Descubre empresas con salud financiera